All Stories

  1. RespiCellTM: An Innovative Dissolution Apparatus for Inhaled Products

    Article • Pharmaceutics, September 2021, MDPI AG

    Francesca BUTTINI

  2. Resistant Tuberculosis: the Latest Advancements of Second-line Antibiotic Inhalation Products

    Article • Current Pharmaceutical Design, April 2021, Bentham Science Publishers

    Francesca BUTTINI

  3. Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction

    Article • Drug Development and Industrial Pharmacy, August 2019, Taylor & Francis

    Dr Fabio Sonvico, Francesca BUTTINI, ERIDE QUARTA

  4. Lipid-core nanocapsules are an alternative to the pulmonary delivery and to increase the stability of statins

    Article • Journal of Microencapsulation, May 2019, Taylor & Francis

    Francesca BUTTINI, Dr Fabio Sonvico

  5. Inhalable chitosan microparticles for simultaneous delivery of isoniazid and rifabutin in lung tuberculosis treatment

    Article • Drug Development and Industrial Pharmacy, April 2019, Taylor & Francis

    Francesca BUTTINI

  6. Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease

    Article • Journal of Drug Targeting, January 2019, Taylor & Francis

    Francesca BUTTINI, Dr Fabio Sonvico, Dr Georgia Valsami

  7. Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α- d -mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy

    Article • International Journal of Pharmaceutics, August 2017, Elsevier

    Francesca BUTTINI

  8. Dual antibiotherapy of tuberculosis mediated by inhalable locust bean gum microparticles

    Article • International Journal of Pharmaceutics, June 2017, Elsevier

    Francesca BUTTINI

  9. Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients

    Article • Drug Development and Industrial Pharmacy, April 2017, Taylor & Francis

    Francesca BUTTINI

  10. Engineered sodium hyaluronate respirable dry powders for pulmonary drug delivery

    Article • International Journal of Pharmaceutics, January 2017, Elsevier

    Francesca BUTTINI

  11. Accessorized DPI: a Shortcut towards Flexibility and Patient Adaptability in Dry Powder Inhalation

    Article • Pharmaceutical Research, September 2016, Springer Science + Business Media

    Francesca BUTTINI

  12. Solid Lipid Nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment⿿A Design of Experiments approach to investigate the influence of pre-freezing conditions on the powder respirability

    Article • International Journal of Pharmaceutics, September 2016, Elsevier

    Francesca BUTTINI

  13. Formulation Strategies for Antitubercular Drugs by Inhalation

    Article • August 2016, Wiley

    Francesca BUTTINI

  14. Overview on gastroretentive drug delivery systems for improving drug bioavailability

    Article • International Journal of Pharmaceutics, August 2016, Elsevier

    Francesca BUTTINI

  15. Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients

    Article • International Journal of Pharmaceutics, April 2016, Elsevier

    Francesca BUTTINI

  16. Effect of Flow Rate onIn VitroAerodynamic Performance of NEXThaler®in Comparison with Diskus®and Turbohaler®Dry Powder Inhalers

    Article • Journal of Aerosol Medicine and Pulmonary Drug Delivery, April 2016, Mary Ann Liebert Inc

    Francesca BUTTINI

  17. High shear mixing of lactose and salmeterol xinafoate dry powder blends: Biopharmaceutic and aerodynamic performances

    Article • Journal of Drug Delivery Science and Technology, December 2015, Elsevier

    Francesca BUTTINI

  18. Loco-regional administration of nanomedicines for the treatment of lung cancer

    Article • Drug Delivery, November 2015, Taylor & Francis

    Dr Fabio Sonvico, Francesca BUTTINI

  19. Multivariate Analysis of Effects of Asthmatic Patient Respiratory Profiles on the In Vitro Performance of a Reservoir Multidose and a Capsule-Based Dry Powder Inhaler

    Article • Pharmaceutical Research, November 2015, Springer Science + Business Media

    Francesca BUTTINI

  20. Formulating powder–device combinations for salmeterol xinafoate dry powder inhalers

    Article • International Journal of Pharmaceutics, July 2015, Elsevier

    Francesca BUTTINI

  21. Floating modular drug delivery systems with buoyancy independent of release mechanisms to sustain amoxicillin and clarithromycin intra-gastric concentrations

    Article • Drug Development and Industrial Pharmacy, June 2015, Informa Healthcare

    Francesca BUTTINI

  22. “Pierce and inhale” design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs

    Article • International Journal of Pharmaceutics, June 2015, Elsevier

    Francesca BUTTINI

  23. Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation

    Article • European Journal of Pharmaceutics and Biopharmaceutics, June 2015, Elsevier

    Francesca BUTTINI

  24. 132 Respirability assessment of amikacin from a novel dry powder inhaler versus nebulized solution

    Article • Journal of Cystic Fibrosis, June 2015, Elsevier

    Francesca BUTTINI

  25. Dissolution: A Critical Performance Characteristic of Inhaled Products?

    Article • May 2015, Wiley

    Francesca BUTTINI

  26. Drug Delivery Strategies for Pulmonary Administration of Antibiotics

    Article • May 2015, Wiley

    Francesca BUTTINI

  27. Spray dried amikacin powder for inhalation in cystic fibrosis patients: A quality by design approach for product construction

    Article • International Journal of Pharmaceutics, August 2014, Elsevier

    Francesca BUTTINI

  28. Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers

    Article • International Journal of Pharmaceutics, April 2014, Elsevier

    Francesca BUTTINI

  29. Pure insulin highly respirable powders for inhalation

    Article • European Journal of Pharmaceutical Sciences, January 2014, Elsevier

    Dr Fabio Sonvico, Francesca BUTTINI

  30. Effect of polymers for aerolization properties of mannitol-based microcomposites containing meloxicam

    Article • European Polymer Journal, September 2013, Elsevier

    Francesca BUTTINI

  31. Multiple dosing of simvastatin inhibits airway mucus production of epithelial cells: Implications in the treatment of chronic obstructive airway pathologies

    Article • European Journal of Pharmaceutics and Biopharmaceutics, August 2013, Elsevier

    Francesca BUTTINI

  32. Complex product composition generates risks for generic substitution also with dosage forms for intravenous administration

    Article • International Journal of Pharmaceutics, July 2013, Elsevier

    Francesca BUTTINI

  33. Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: Loading, enzyme-trigger release and cell uptake

    Article • Journal of Controlled Release, May 2013, Elsevier

    Francesca BUTTINI

  34. Quality of Inhalation Products: Specifications

    Article • February 2013, Wiley

    Francesca BUTTINI

  35. Aerodynamic Assessment for Inhalation Products: Fundamentals and Current Pharmacopoeial Methods

    Article • February 2013, Wiley

    Francesca BUTTINI

  36. Inhalation Drug Delivery

    Article • January 2013, Wiley

    Francesca BUTTINI

  37. Biological In Vitro Models for Absorption by Non-Oral Routes

    Article • January 2013, Elsevier

    Francesca BUTTINI

  38. Nanostructures for Overcoming the Pulmonary Barrier: Drug Delivery Strategies

    Article • July 2012, Royal Society of Chemistry

    Dr Fabio Sonvico, Francesca BUTTINI

  39. Particles and powders: Tools of innovation for non-invasive drug administration

    Article • Journal of Controlled Release, July 2012, Elsevier

    Dr Fabio Sonvico, Francesca BUTTINI

  40. Layered lipid microcapsules for mesalazine delayed-release in children

    Article • International Journal of Pharmaceutics, December 2011, Elsevier

    Francesca BUTTINI

  41. Pulmonary Spray Dried Powders of Tobramycin Containing Sodium Stearate to Improve Aerosolization Efficiency

    Article • Pharmaceutical Research, January 2009, Springer Science + Business Media

    Francesca BUTTINI